Mirum Pharmaceuticals (MIRM) Interest & Investment Income (2019 - 2026)

Mirum Pharmaceuticals' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 12.5% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $13.1 million (down 0.58% YoY), while the FY2025 annual figure was $12.7 million, down 7.72% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $3.4 million, down from $3.4 million in the prior quarter.
• The five-year high for Interest & Investment Income was $4.1 million in Q3 2023, with the low at $69000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $3.3 million (2025), against an average of $2.8 million.
• Peak annual rise in Interest & Investment Income reached 3196.92% in 2022, while the deepest fall reached 53.69% in 2022.
• Mirum Pharmaceuticals' Interest & Investment Income stood at $2.1 million in 2022, then surged by 76.15% to $3.8 million in 2023, then decreased by 15.13% to $3.2 million in 2024, then rose by 6.74% to $3.4 million in 2025, then declined by 0.56% to $3.4 million in 2026.
• Business Quant data shows MIRM's Interest & Investment Income at $3.4 million in Q1 2026, $3.4 million in Q4 2025, and $3.3 million in Q3 2025.